The country’s largest clinical study investigating the best gap between first and second COVID-19 vaccine doses for pregnant women has launched in Greater Manchester.
The exceptional contribution of three MFT colleagues to research and innovation has been recognised by the Manchester Academic Health Science Centre (MAHSC).
For nine-year-old Leo, and his mum, Lisa, taking part in a clinical trial at the NIHR Manchester Clinical Research Facility has been important for many reasons.
Patients at Manchester Adult Cystic Fibrosis Centre are the first in Europe to have received the life-changing drug, Kaftrio, as part of standard NHS care.
For three-year-old Elliott, who has a rare genetic disorder, life has been transformed by taking part in a clinical trial at Manchester Clinical Research Facility (CRF).